Ming-Lung Yu

Get in Touch

Email: d780178@kmu.edu.tw

Education

Hospital Appointments

Other Professional Positions

Honors and Awards

Publications

1. Liao, Y. C., W. W. Chou, Y. N. Li, S. C. Chuang, W. Y. Lin, B. V. Lakkakula, M. L. Yu and S. H. Juo. "Apelin Gene Polymorphism Influences Apelin Expression and Obesity Phenotypes in Chinese Women." Am J Clin Nutr 94, no. 3 (2011): 921-8
2. Liao, Y. C., Y. S. Wang, Y. C. Guo, K. Ozaki, T. Tanaka, H. F. Lin, M. H. Chang, K. C. Chen, M. L. Yu, S. H. Sheu and S. H. Juo. "Brap Activates Inflammatory Cascades and Increases the Risk for Carotid Atherosclerosis." Mol Med 17, no. 9-10 (2011): 1065-74.
3. Dai, C. Y., M. L. Yeh, J. F. Huang, W. L. Chuang and M. L. Yu. "Insurance Status and Treatment Candidacy of Patients with Hepatitis C: Taiwanese Patients Are Luckier." Hepatology 53, no. 4 (2011): 1399; author reply 1400.
4. Yu, M. L., C. H. Liu, C. F. Huang, T. C. Tseng, J. F. Huang, C. Y. Dai, Z. Y. Lin, S. C. Chen, L. Y. Wang, S. H. Juo, W. L. Chuang and J. H. Kao. "Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin." PLoS One 7, no. 12 (2012): e52048.a
5. Huang, C. F., M. L. Yeh, J. F. Huang, J. F. Yang, M. Y. Hsieh, Z. Y. Lin, S. C. Chen, L. Y. Wang, E. Hsi, S. H. Juo, C. Y. Dai, W. L. Chuang and M. L. Yu. "Host Interleukin-28b Genetic Variants Versus Viral Kinetics in Determining Responses to Standard-of-Care for Asians with Hepatitis C Genotype 1." Antiviral Res 93, no. 2 (2012): 239-44.
6. Hsieh, M. H., W. Y. Lin, H. H. Chien, L. H. Chien, C. K. Huang, J. F. Yang, N. C. Chang, C. F. Huang, C. L. Wang, W. L. Chuang, M. L. Yu, C. Y. Dai and C. K. Ho. "Waist Circumference, Body Mass Index, Serum Uric Acid, Blood Sugar, and Triglyceride Levels Are Important Risk Factors for Abnormal Liver Function Tests in the Taiwanese Population." Kaohsiung J Med Sci 28, no. 9 (2012): 470-6.
7. Huang, J. F., M. L. Yu, C. F. Huang, S. H. Juo, C. Y. Dai, M. Y. Hsieh, N. J. Hou, M. L. Yeh, M. H. Hsieh, J. F. Yang, Z. Y. Lin, S. C. Chen, S. J. Shin and W. L. Chuang. "The Outcomes of Glucose Abnormalities in Pre-Diabetic Chronic Hepatitis C Patients Receiving Peginterferon Plus Ribavirin Therapy." Liver Int 32, no. 6 (2012): 962-9.
8. Huang, C. F., C. Y. Dai, M. L. Yeh, J. F. Huang, C. I. Huang, M. Y. Hsieh, Z. Y. Lin, S. C. Chen, L. Y. Wang, S. H. Juo, W. L. Chuang, Y. C. Lin and M. L. Yu. "Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients." PLoS One 8, no. 3 (2013): e58882.
9. Huang, C. I., C. F. Huang, J. F. Huang, C. Y. Dai, M. L. Yeh, M. Y. Hsieh, Z. Y. Lin, S. C. Chen, L. Y. Wang, M. L. Yu and W. L. Chuang. "The Treatment Efficacy of Pegylated Interferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Mixed Genotype 1/2 Infection." J Gastroenterol Hepatol, (2013).
10. Huang, J. F., M. L. Yu, C. Y. Dai and W. L. Chuang. "Glucose Abnormalities in Hepatitis C Virus Infection." Kaohsiung J Med Sci 29, no. 2 (2013): 61-8.
11. Yang, H. C., C. L. Chen, Y. C. Shen, C. Y. Peng, C. J. Liu, T. C. Tseng, T. H. Su, W. L. Chuang, M. L. Yu, C. Y. Dai, C. H. Liu, P. J. Chen, D. S. Chen and J. H. Kao. "Distinct Evolution and Predictive Value of Hepatitis B Virus Precore and Basal Core Promoter Mutations in Interferon-Induced Hepatitis B E Antigen Seroconversion." Hepatology 57, no. 3 (2013): 934-43.
12. Chuang, W. L. and M. L. Yu. "Host Factors Determining the Efficacy of Hepatitis C Treatment." J Gastroenterol 48, no. 1 (2013): 22-30.
13. Dai, C. Y., W. L. Chuang and M. L. Yu. "A 24-Week Peg-Interferon Alpha-2b Versus a 12-Week Peg-Interferon Alpha-2b Alone or with Ribavirin for Patients with Acute Hepatitis C." Hepatology, (2014).
14. Dai, C. Y., W. L. Chuang and M. L. Yu. "Variants of the Inosine Triphosphate Pyrophosphatase Gene and Relapse Risk Following Treatment for Hcv Genotype 2/3." Hepatology, (2014).
15. Hsi, E., C. F. Huang, C. Y. Dai, S. H. Juo, W. W. Chou, J. F. Huang, M. L. Yeh, Z. Y. Lin, S. C. Chen, L. Y. Wang, W. L. Chuang and M. L. Yu. "Peripheral Blood Mononuclear Cells Microrna Predicts Treatment Outcome of Hepatitis C Virus Genotype 1 Infection." Antiviral Res, (2014).
16. Yu, M. L., C. Y. Dai, C. F. Huang, J. J. Lee, M. L. Yeh, S. M. Yeh, H. T. Kuo, J. F. Huang, J. M. Chang, H. C. Chen, S. H. Juo, S. J. Hwang, W. L. Chuang and Formosa-Like group. "High Hepatitis B Virus Surface Antigen Levels and Favorable Interleukin 28b Genotype Predict Spontaneous Hepatitis C Virus Clearance in Uremic Patients." J Hepatol 60, no. 2 (2014): 253-9
17. Huang, C. F., M. L. Yeh, P. C. Tsai, M. H. Hsieh, H. L. Yang, M. Y. Hsieh, J. F. Yang, Z. Y. Lin, S. C. Chen, L. Y. Wang, C. Y. Dai, J. F. Huang, W. L. Chuang and M. L. Yu. "Baseline Gamma-Glutamyl Transferase Levels Strongly Correlate with Hepatocellular Carcinoma Development in Non-Cirrhotic Patients with Successful Hepatitis C Virus Eradication." J Hepatol, (2014).
18. Jeng, J. E., M. F. Tsai, H. R. Tsai, L. Y. Chuang, Z. Y. Lin, M. Y. Hsieh, S. C. Chen, W. L. Chuang, L. Y. Wang, M. L. Yu, C. Y. Dai and J. F. Tsai. "Impact of Chronic Hepatitis B and Hepatitis C on Adverse Hepatic Fibrosis in Hepatocellular Carcinoma Related to Betel Quid Chewing." Asian Pac J Cancer Prev 15, no. 2 (2014): 637-42.